Project leader: Gonghong Wei, Ph.D.
Biocenter Oulu and Department of Medical Biochemistry and Molecular Biology, Institute of Biomedicine, Faculty of Medicine, University of Oulu
P.O.Box 5000, FIN-90014 University of Oulu, Finland
Aapistie 5A, 90220 Oulu, Finland
Tel. +358-(0)294 486111,
Fax +358-8-537 6115,
e-mail: gonghong.wei (at) oulu.fi
Transcription factors (TF) are sequence-specific DNA-binding proteins. Human genome contains approximately 1400 TFs contributing to complex gene regulation and accurate cell growth control. The aberrant expression of TFs is frequently observed in cancer of the breast and prostate, Ewing's sarcoma and leukemia. Charting gene regulatory networks driven by the TFs in cancer cells is a systematic way to the discovery of novel mechanisms and clinical markers for cancer risk prediction and therapy. Here, we aim to uncover cancerous roles of several TFs including key members of ETS, HOX and Forkhead classes of DNA-binding proteins. Together with the data from genome-wide association studies, we aim to see how cancer risk-associated SNPs alter TF DNA-binding to clinically important enhancers. We will validate key findings including risk SNPs, enhancers and genes that are potentially to be prognostic and diagnostic markers for human cancer risk prediction.